A 42-year-old woman presents to the outpatient clinic with a 5-day history of fever, severe headache, neck stiffness, and photophobia. On examination, she has a positive Kernig sign and Brudzinski sign. CSF analysis shows: WBC 850/µL (90% neutrophils), protein 180 mg/dL, glucose 28 mg/dL (serum glucose 120 mg/dL), and CSF:serum glucose ratio 0.23. Gram stain of CSF shows Gram-positive diplococci. Culture is pending. What is the most appropriate empiric antibiotic therapy?

Explanation

## Clinical Diagnosis **Key Point:** This is acute bacterial meningitis with CSF findings and Gram stain morphology consistent with Streptococcus pneumoniae. ### CSF Analysis Interpretation | Parameter | Value | Interpretation | |-----------|-------|----------------| | WBC | 850/µL (90% PMN) | Acute bacterial meningitis | | Protein | 180 mg/dL | Markedly elevated (bacterial pattern) | | Glucose | 28 mg/dL | Severely reduced | | CSF:serum glucose ratio | 0.23 | <0.4 = bacterial meningitis | | Gram stain | Gram-positive diplococci | S. pneumoniae (lancet-shaped) | **Clinical Pearl:** The combination of low CSF glucose (hypoglycorrhachia) with high protein and neutrophilic pleocytosis is pathognomonic for bacterial meningitis. CSF:serum glucose ratio <0.4 is highly specific for bacterial (not viral) meningitis. ### Empiric Therapy for Pneumococcal Meningitis **High-Yield:** Empiric meningitis coverage in India MUST include: 1. **Ceftriaxone** (or cefotaxime) — 3rd-generation cephalosporin with excellent CSF penetration (20–30% of serum levels) 2. **Vancomycin** — added because penicillin-resistant S. pneumoniae (PRSP) is endemic in India; vancomycin achieves adequate CSF levels with high-dose regimens 3. **Ampicillin** — covers Listeria monocytogenes (which can coexist in immunocompromised patients and is cephalosporin-resistant) **Mnemonic:** **CVA** = **C**eftriaxone + **VA**ncomycin + **A**mpicillin for empiric bacterial meningitis in India. ### Why This Combination? - **Ceftriaxone 2 g IV 12-hourly** (total 4 g/day) achieves CSF concentrations of 0.5–2 µg/mL (adequate for PRSP with MIC ≤ 0.5 µg/mL) - **Vancomycin 15–20 mg/kg IV 8–12-hourly** (target CSF level 15–20 µg/mL) is essential for high-level penicillin resistance - **Ampicillin 2 g IV 4-hourly** covers Listeria (which is resistant to cephalosporins) **Warning:** Do NOT use penicillin monotherapy — PRSP prevalence in India is >30%, and penicillin CSF levels are inadequate for meningitis. Do NOT omit vancomycin or ampicillin in empiric therapy. ### Definitive Therapy After Culture Once culture and susceptibility results are available: - If **penicillin-susceptible S. pneumoniae** (MIC ≤ 0.06 µg/mL): penicillin G monotherapy - If **intermediate resistance** (MIC 0.12–1 µg/mL): continue ceftriaxone + vancomycin - If **high-level resistance** (MIC ≥ 2 µg/mL): continue ceftriaxone + vancomycin ± rifampicin **Clinical Pearl:** Dexamethasone (10 mg IV 6-hourly × 4 days) should be given concurrently with the first antibiotic dose to reduce CNS inflammation and improve outcomes.